News

The $590,000 grant will support the program which focuses on the impact of maternal immunity against RSV on the generation of a protective immune response in newborns. GenVec

As a part of the agreement, Cara is eligible to gain an up-front payment, as well as an equity investment. Cara could even gain further milestone payments related

In the controlled Phase 2 clinical trial, SCCHN patients were treated either with IMO-2055 at a dose of 0.32mg/kg given subcutaneously once weekly in combination with weekly cetuximab,

Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). Sunesis executive vice president and Development chief marketing officer Adam Craig

Actemra is the first humanized IL-6 receptor-inhibiting monoclonal antibody approved for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an

The grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), will help develop the trivalent vaccine

XCAT-KS is a PCR / pyrosequencing based bloodless test which identifies KS and other male sex chromosome aneuploidies with 100% sensitivity and specificity. The company said, following receipt

Acella Pharmaceuticals, a specialty pharmaceutical company, has received approval of an Abbreviated New Drug Application (ANDA) for Gabapentin Oral Solution, 250 mg/5ml. The US Food and Drug Administration

The company said it will invest millions over the next year in two capital projects at its Merck Road packaging facility. The two projects include renovating existing manufacturing